| |
| |
|
| Insider
Information: |
Opaleye Management Inc. |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
11,342,009 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$83,435,137 |
|
|
| Total
Shares |
11,342,009 |
|
|
| Total
Value |
$83,435,137 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
123
|
10
|
|
Stock
price went up :
|
64
|
1
|
| Stock
price went down : |
59
|
9
|
| |
|
|
|
Gain/Loss Ratio : |
1.1
|
1.1
|
| Percentage
Gain/Loss : |
 16.5%
|
 -233.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Harrow Health Inc |
HROW |
10% Owner |
2015-05-19 |
0 |
2024-04-25 |
3,815,000 |
Premium* |
|
|
Ocular Therapeutix, Inc |
OCUL |
10% Owner |
|
0 |
2020-01-02 |
4,918,500 |
Premium* |
|
|
Eton Pharmaceuticals, Inc. |
ETON |
10% Owner |
|
0 |
2021-11-17 |
2,375,000 |
Premium* |
|
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2020-08-27 |
0 |
2023-11-10 |
0 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
10% Owner |
2020-09-24 |
0 |
2024-05-31 |
108,696 |
Premium* |
|
|
Tela Bio, Inc. |
TELA |
10% Owner |
2022-06-10 |
0 |
2022-11-03 |
124,813 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2020-09-24 |
4 |
B |
$16.87 |
$5,061,000 |
I/I |
300,000 |
2,408,472 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2020-09-30 |
4 |
B |
$16.00 |
$800,000 |
I/I |
50,000 |
2,458,472 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2023-09-19 |
4 |
B |
$14.65 |
$205,366 |
I/I |
14,017 |
3,614,017 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2023-09-20 |
4 |
B |
$14.49 |
$86,710 |
I/I |
5,983 |
3,620,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-03-28 |
4 |
B |
$12.82 |
$641,000 |
I/I |
50,000 |
3,745,600 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-04-19 |
4 |
B |
$10.56 |
$310,391 |
I/I |
29,400 |
3,775,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2022-12-14 |
4 |
B |
$10.52 |
$4,536,045 |
I/I |
431,183 |
175,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-04-23 |
4 |
B |
$10.29 |
$120,547 |
I/I |
11,715 |
3,786,715 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-04-24 |
4 |
B |
$10.15 |
$84,093 |
I/I |
8,285 |
3,795,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-04-25 |
4 |
B |
$9.97 |
$199,400 |
I/I |
20,000 |
3,815,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2022-09-28 |
4 |
B |
$9.77 |
$108,354 |
I/I |
11,085 |
158,817 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-03-20 |
4 |
B |
$9.65 |
$488,290 |
I/I |
50,600 |
3,695,600 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2021-08-18 |
4 |
B |
$8.64 |
$401,979 |
I/I |
46,500 |
147,500 |
1.5 |
% |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2021-05-26 |
4 |
S |
$8.57 |
$585,331 |
I/I |
(68,300) |
150,200 |
0 |
- |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2021-08-17 |
4 |
B |
$8.57 |
$222,719 |
I/I |
26,000 |
146,000 |
1.5 |
% |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2021-05-25 |
4 |
S |
$8.53 |
$409,440 |
I/I |
(48,000) |
153,000 |
0 |
- |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-08-10 |
4 |
B |
$8.52 |
$102,089 |
I/I |
11,979 |
105,000 |
1.5 |
% |
|
| ETON |
Eton Pharmaceuticals, Inc... |
10% Owner |
– – • |
2021-05-27 |
4 |
S |
$8.49 |
$1,069,740 |
I/I |
(126,000) |
145,600 |
0 |
- |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2021-08-19 |
4 |
B |
$8.45 |
$443,363 |
I/I |
52,500 |
150,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2021-06-18 |
4 |
B |
$8.35 |
$528,688 |
I/I |
63,322 |
140,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2021-06-17 |
4 |
B |
$8.32 |
$93,701 |
I/I |
11,262 |
136,478 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-08-16 |
4 |
B |
$8.10 |
$42,285 |
I/I |
5,221 |
120,217 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-09-15 |
4 |
B |
$8.10 |
$33,680 |
I/I |
4,158 |
120,875 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-09-19 |
4 |
B |
$8.09 |
$145,584 |
I/I |
18,000 |
122,247 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-07-20 |
4 |
B |
$8.08 |
$41,192 |
I/I |
5,100 |
99,167 |
1.5 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
